series-b
Stage
1
Investors
About
NanoCellect Biomedical develops innovative microfluidic-based cell sorting technologies that enable gentle, high-viability sorting of cells for applications including antibody discovery, cell line development, single-cell omics, and plant and animal genomics.
Explore NanoCellect Biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.